Results 11 to 20 of about 2,048,757 (259)

Reactive Astrocytes in Brain Metastasis [PDF]

Frontiers in Oncology, 2017
Brain metastasis, the secondary growth of malignant cells within the central nervous system (CNS), exceeds the incidence of primary brain tumors (i.e., gliomas) by tenfold and are seemingly on the rise owing to the emergence of novel targeted therapies ...
David Wasilewski, Neibla Priego, Coral Fustero-Torre, Manuel Valiente   +3 more
doaj   +2 more sources

Recent Update on Neurosurgical Management of Brain Metastasis [PDF]

, 2022
Brain metastasis (BM), classified as a secondary brain tumor, is the most common malignant central nervous system tumor whose median overall survival is approximately 6 months.
박현호, 장종희, 강석구, 유지환   +3 more
core   +1 more source

Brain metastasis from extramammary Paget’s disease [PDF]

, 2020
2020-11Herein, we present a case of extramammary Paget’s disease with brain metastasis that was diagnosed pathologically for the first time in Japan. Moreover, invasive extramammary Paget’s disease (with distant metastasis) highly resistant to treatment.
Hanyu, Taketo, Fujitani, Shigeru, Mizutani, Nobuhiko, Ito, Ai   +3 more
core   +1 more source

A National Consensus Survey for Current Practice in Brain Tumor Management III: Brain Metastasis and Primary Central Nervous System Lymphoma [PDF]

, 2020
Background: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted the nationwide questionnaire survey for diverse queries facing to treat patients with brain tumor.
김세훈, 윤홍인, 장종희
core   +1 more source

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

npj Precision Oncology, 2021
PARP inhibitors are approved for the treatment of solid tumor types that frequently harbor alterations in the key homologous recombination (HR) genes, BRCA1/2.
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, David Szuts, Zoltan Szallasi   +13 more
doaj   +1 more source

Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases

Advances in Radiation Oncology, 2022
Purpose: Stereotactic radiosurgery (SRS) is a highly effective therapy for newly diagnosed brain metastases. Prophylactic antiepileptic drugs are no longer routinely used in current SRS practice, owing to a perceived low overall frequency of new-onset ...
Emily C. Lerner, BA, Ethan S. Srinivasan, BS, Gloria Broadwater, MS, Aden P. Haskell-Mendoza, MS, Ryan M. Edwards, BA, David Huie, MD, Eugene J. Vaios, MD, MBA, Scott R. Floyd, MD, PhD, Justus D. Adamson, PhD, Peter E. Fecci, MD, PhD   +9 more
doaj   +1 more source

Pheochromocytoma with Brain Metastasis: A Extremely Rare Case in Worldwide. [PDF]

, 2018
Pheochromocytoma (PCC) is a neuroendocrine tumor that mainly arises from the medulla of the adrenal gland. Some PCCs become malignant and metastasize to other organs.
조윤성, 김세훈, 강석구
core   +1 more source

Lower gingival squamous cell carcinoma with brain metastasis during long-term cetuximab treatment: A case report [PDF]

, 2018
Long-term cetuximab treatment can lead to acquired resistance, and tumor progression and/or new lesions often occur. The present report describes a case of lower gingival squamous cell carcinoma with brain metastasis during long-term cetuximab treatment ...
Mitsuko Tokuhisa, Tsuchihashi, Hiroki, Yuki Sakamoto, Masahiro Umeda, Sakamoto, Yuki, Umeda, Masahiro, Yanamoto, Souichi, Souichi Yanamoto, Tokuhisa, Mitsuko, Kohei Okuyama, Naruse, Tomofumi, Okuyama, Kohei, Tomofumi Naruse, Hiroki Tsuchihashi   +13 more
core   +1 more source

Perspective on nanochannels as cellular mediators in different disease conditions

Cell Communication and Signaling, 2018
Tunnelling nanotubes (TNTs), also known as membrane nanochannels, are actin-based structures that facilitate cytoplasmic connections for rapid intercellular transfer of signals, organelles and membrane components.
Eshna Jash, Peeyush Prasad, Naveen Kumar, Taruna Sharma, Aaron Goldman, Seema Sehrawat   +5 more
doaj   +1 more source

Systemic Therapy Type and Timing Effects on Radiation Necrosis Risk in HER2+ Breast Cancer Brain Metastases Patients Treated With Stereotactic Radiosurgery

Frontiers in Oncology, 2022
BackgroundThere is a concern that HER2-directed systemic therapies, when administered concurrently with stereotactic radiosurgery (SRS), may increase the risk of radiation necrosis (RN).
Christine Park, Evan D. Buckley, Amanda E. D. Van Swearingen, Amanda E. D. Van Swearingen, Will Giles, James E. Herndon, James E. Herndon, John P. Kirkpatrick, John P. Kirkpatrick, John P. Kirkpatrick, Carey K. Anders, Carey K. Anders, Scott R. Floyd, Scott R. Floyd   +13 more
doaj   +1 more source